Introduction of medical products into healthcare practice and costs reimbursement: European experience
in the present article, we review the ways of introducing medical products into healthcare practice in countries of the european Union and compare them with the Russian experience. in this analysis, we underscore the existing differences but also identify the common aspects, for example, the mandato...
Saved in:
Main Authors: | V. V. Omelyanovsky (Author), S. S. Otstavnov (Author), N. Z. Musina (Author), V. S. Dombrovskii (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021) -
International experience in determining the cost-effectiveness thresholds
by: T. P. Bezdenezhnykh, et al.
Published: (2019) -
The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018) -
The Impact of the Introduction of the Additional Roles Reimbursement Scheme on the General Practice Nursing Workforce in England
by: Alison Leary, et al.
Published: (2024) -
Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries
by: Jesper Jørgensen, et al.
Published: (2020)